Month: February 2020

MCH Group AG: Beantwortung weiterer AktionärsfragenDie AMG Fondsverwaltung AG, vertreten durch Erhard Lee und als Vertreterin der Gruppe AMG (bestehend aus Ursula Lee, Erhard Lee und LLB Swiss Investment AG, handelnd für die AMG Substanzwerte Schweiz), hat anlässlich der ausserordentlichen Generalversammlung vom 29. Januar 2020 diverse Zusatzfragen gestellt. Sie hat sich mit dem Vorgehen einverstanden erklärt, dass die Fragen gesammelt und im Nachgang zur ausserordentlichen Generalversammlung schriftlich beantwortet und veröffentlicht werden.In Absprache mit der MCH Group hat die AMG Fondsverwaltung AG nach der ausserordentlichen Generalversammlung den zusätzlichen Fragenkatalog schriftlich zusammengefasst und am 11. Februar 2020 eingereicht. Die Antworten zu den von der AMG Fondsverwaltung AG gestellten Zusatzfragen sind auf der Webseite...

MCH Group SA: Réponses aux questions supplémentaires des actionnairesAMG Fondsverwaltung AG, représentée par Erhard Lee et en tant que représentante du groupe AMG (composé d’Ursula Lee, Erhard Lee et de LLB Swiss Investment AG, agissant pour le compte d’AMG Substanzwerte Schweiz), a posé diverses questions supplémentaires lors de l’assemblée générale extraordinaire du 29 janvier 2020. Elle a accepté la procédure selon laquelle les questions seraient collectées et feraient l’objet d’une réponse écrite et d’une publication à la suite de l’assemblée générale extraordinaire.En consultation avec MCH Group, AMG Fondsverwaltung AG a, après l’assemblée générale extraordinaire, résumé par écrit la liste de questions supplémentaires et l’a soumise le 11 février 2020. Les réponses aux questions supplémentaires posées par AMG Fondsverwaltung AG peuvent...

MCH Group Ltd.: Answers to further shareholder questionsAMG Fondsverwaltung AG, represented by Erhard Lee and representing the AMG Group (comprising Ursula Lee, Erhard Lee and LLB Swiss Investment AG, acting for AMG Substanzwerte Schweiz), asked various additional questions on the occasion of the Extraordinary General Meeting on 29 January 2020. It agreed to a procedure whereby the questions would be collected and then answered in writing and published following the Extraordinary General Meeting.In consultation with the MCH Group, AMG Fondsverwaltung AG drew up a list of the additional questions in writing after the Extraordinary General Meeting and submitted this on 11 February 2020. The answers to the additional questions submitted by AMG Fondsverwaltung AG are posted (in German) on the MCH Group website under “MCH Group”...

Next Games Corporation Company Release February 28, 2020 08:00 EETNext Games Corporation’s Financial Statements Bulletin for January-December 2019 contains financial data for H2/2019 and full-year 2019. Next Games’ Financial Statements Bulletin 2019 is attached to this release and available at www.nextgames.com/reportsJanuary-December 2019 in shortRevenue was EUR 34.7 (35.2) millionGross Profit declined by three percentage points and was EUR 19.7 million, 57% of revenue (21.3; 60%)EBIT was EUR -7.4 (-16.9) millionAdjusted Operating profit improved EUR 9.8 million and was EUR -4.0 (-13.8) millionEBITDA was EUR -3.5 (-14.8) millionThe group’s publishing operations turned profitable with an EBITDA of EUR 3.8 (-4.5)millionProduct development costs were EUR 6.6 (7,5) million, 19% (21%) of revenueThe company had 107 (140) employees at...

Next Games Oyj yhtiötiedote 28.2.2019 klo 08:00Next Games Oyj:n tilinpäätöstiedote tammi-joulukuulta 2019 sisältää taloustietoja heinä-joulukuulta 2019 sekä koko vuodelta 2019. Tilinpäätöstiedote on liitteenä tässä tiedotteessa ja saatavilla osoitteessa www.nextgames.com/fi/raportit.NEXT GAMES OYJ: TILINPÄÄTÖSTIEDOTE 1.1.-31.12.20191.1.-31.12.2019 lyhyestiLiikevaihto oli 34,7 (35,2) miljoonaa euroaBruttokate laski kolme prosenttiyksikköä ja oli 19,7 miljoonaa euroa, eli 57 % yhtiön liikevaihdosta (21,3;  60 %)Liiketulos (EBIT) oli -7,4 (-16,9) miljoonaa euroaOikaistu liiketulos parani 9,8 miljoonaa euroa ja oli -4,0 (-13,8) miljoonaa euroaKäyttökate (EBITDA) oli -3,5 (-14,8) miljoonaa euroaJulkaisutoiminnan käyttökate (EBITDA) kääntyi kannattavaksi ja oli 3,8 (-4,5) miljoonaa euroaTuotekehitysmenot olivat 6,6 (7,5) miljoonaa euroa, eli...

Oslo, Norway, 28 February 2020Vistin Pharma ASA (Vistin Pharma, OSE: VISTIN), announces that the company has reduced its exposure to the spread between ICE low sulphur gasoil and Sing380.The changed exposure has been carried out by reducing the position in ICE low sulphur gasoil with 5,000MT in April and 25,000MT in December while keeping the exposure to the SING380 unchanged.The transaction has been carried out to reduce the remaining overall risk in the portfolio of oil derivatives under the current market conditions.The transaction resulted in a loss of approximately 46.5 million.                        After the transactions, excluding the contracts that expire in February, the remaining positions are long in the spread between Gasoil versus Sing380 with 47,600MT and short on Sing380 with 30,000MT:As previously communicated, any changes...

Profit of “Grindeks” reaches 12.9 million euros in 2019Today, on 28 February, the JSC “Grindeks” submitted the non-audited consolidated financial statements of 2019 to Nasdaq Riga. Non-audited financial results indicate that the Group’s profit in 2019 attributable to shareholders of the parent company was 12.9 million euro. The Group’s turnover in 2019 was 141.4 million euro. In 2019, the Group’s production was exported to 84 countries worldwide, a total of 132.0 million euro.The Chairman of the Board of JSC “Grindeks” Juris Hmelnickis: “The last year was a success as we managed to reach 12.9 million euro in profit – this is a guarantee for the further development of the Group. In the recent years, the pharmaceutical industry has been changing, and now pharmaceutical businesses must operate in an environment where customer needs are becoming...

2019. gadā „Grindeks” peļņa sasniedz 12,9 milj. eiroŠodien, 28. februārī, akciju sabiedrības „Grindeks” „Nasdaq Riga” iesniegtie 2019. gada nerevidētie konsolidētie finanšu pārskati liecina, ka koncerna peļņa, kas attiecināma uz mātes sabiedrības akcionāriem, ir sasniegusi 12,9 milj. eiro. Koncerna apgrozījums 2019. gadā bija 141,4 milj. eiro. 2019. gadā Koncerna saražotā produkcija tika eksportēta uz 84 pasaules valstīm kopumā par 132,0 milj. eiro.AS „Grindeks” valdes priekšsēdētājs Juris Hmeļņickis: „2019. gads ir sekmīgi noslēdzies, sasniedzot 12,9 milj. eiro peļņu, kas ir garants tālākai koncerna attīstībai. Pēdējos gados farmācijas biznesa vide mainās, un farmācijas industrija darbojas apstākļos, kuros klientu vajadzības kļūst aizvien specifiskākas. „Grindeks” koncerna potenciāls sniegt pacientu vajadzībām piemērotus risinājumus...

Orphazyme A/SCompany announcement                                                                                       No. 20/2020                                                                                                          Company Registration No. 32266355Copenhagen, Denmark, February 28, 2020 – Orphazyme A/S (ORPHA.CO), a biopharmaceutical company pioneering Heat-Shock Protein response for the treatment of neurodegenerative orphan diseases, today announces its Annual Report for the period January 1–December 31, 2019. Kim Stratton, Chief Executive Officer of Orphazyme, said “2019 was an exceptional year for Orphazyme. We delivered on key priorities with our late-stage programs in Niemann-Pick disease Type C, sporadic Inclusion Body Myositis and Amyotrophic Lateral Sclerosis and continued to advance our proof-of-concept phase...

Next Games Corporation Company Release February 28, 2020 at 07:58 a.m. EETNext Games is applying a change to its accounting policy relating to its research and development, sales and marketing as well as administrative functions. With the change, the company aims to improve its financial communication by providing investors more understandable, comprehensible and better structured financial information regarding the company’s product development and publishing operations in its financial reporting.The accounting policy change relates to the classification of development costs for published products. Previously all game development costs, both for published and unpublished games, were reported under the Research and Development function. In the future development activities relating to published games are reported as part of the group’s...